Conavi Medical Corp. CNVI.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · conavi.com
Conavi Medical Corp. is a commercial-stage medical device company that designs, manufactures, and markets intravascular imaging technologies for minimally invasive cardiovascular procedures. The company's Novasight Hybrid System combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) for simultaneous, co-registered imaging of coronary arteries, and holds regulatory approvals from Health Canada, the FDA, China's NMPA, and Japan's Ministry of Health.
Key ratios
FreeCashFlowOnSale TTM -29.31
FreeCashFlowOnSale 2025 -2.76
FreeCashFlowOnSale 2024 -9.59
FreeCashFlowOnSale 2023 -8.74
NetIncomeMargin TTM -2.25
NetIncomeMargin 2025 -2.25
ReturnOnAssets TTM -0.88
ReturnOnAssets 2025 -0.88
ReturnOnAssets 2024 -0.98
ReturnOnAssets 2023 -0.68
Recent news
Conavi Medical Announces Pricing of Public Offering of Common Shares and/or Pre-Funded Warrants
2026-07-29 · GlobeNewswire
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
2026-05-28 · BioSpace
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
2026-05-11 · GlobeNewswire
Conavi Medical Awarded 2026 TAG Innovation Award
2026-04-23 · GlobeNewswire